Nasdaq - Delayed Quote USD

Vanguard PRIMECAP Inv (VPMCX)

162.96
+0.81
+(0.50%)
At close: 8:04:24 PM EDT

Top 10 Holdings (36.40% of Total Assets)

SymbolCompany% Assets
Eli Lilly and Company 10.51%
Boston Scientific Corporation 3.54%
Amgen Inc. 3.47%
Microsoft Corporation 2.98%
KLA Corporation 2.92%
Micron Technology, Inc. 2.87%
FedEx Corporation 2.74%
AstraZeneca PLC 2.62%
Texas Instruments Incorporated 2.53%
Siemens Aktiengesellschaft 2.23%

Sector Weightings

SectorVPMCX
Healthcare   30.25%
Technology   28.10%
Industrials   13.26%
Energy   2.33%
Real Estate   0.00%
Utilities   0.00%

Overall Portfolio Composition (%)

Cash 1.59%
Stocks 98.41%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average VPMCX Category Average
Price/Earnings 0.04 0.04
Price/Book 0.27 0.21
Price/Sales 0.44 0.4
Price/Cashflow 0.07 0.06
Median Market Cap 169,883.09 335,222.28
3 Year Earnings Growth 9.63 21.25

Bond Holdings

Average VPMCX Category Average
Maturity -- --
Duration -- 4.6
Credit Quality -- --

Performance & Risk

YTD Return 0.96%
5y Average Return 14.69%
Rank in Category (ytd) 21
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.97
Morningstar Risk Rating

Fund Overview

Category Large Blend
Fund Family Vanguard
Net Assets 69.35B
YTD Return -2.88%
Yield 0.94%
Morningstar Rating
Inception Date Nov 12, 2001

Fund Summary

The fund invests in stocks considered to have above-average earnings growth potential that is not reflected in their current market prices. Its portfolio consists predominantly of large- and mid-capitalization stocks.

Related Tickers